当前位置:首页 - 行情中心 - 赛升药业(300485) - 财务分析 - 现金流量表

赛升药业

(300485)

  

流通市值:23.69亿  总市值:41.66亿
流通股本:2.74亿   总股本:4.82亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金217,336,616.71110,983,425.49476,536,386.56350,257,520.72
  收到的税费返还--2,345,343.292,346,593.29
  收到其他与经营活动有关的现金4,624,539.87904,322.387,884,244.371,417,318.07
  经营活动现金流入小计221,961,156.58111,887,747.87486,765,974.22354,021,432.08
  购买商品、接受劳务支付的现金59,479,181.2535,237,595.21108,427,218.7875,504,042.84
  支付给职工以及为职工支付的现金36,840,903.0517,934,416.1576,682,799.7857,841,323.93
  支付的各项税费20,564,114.647,250,087.3960,597,665.8644,020,780.26
  支付其他与经营活动有关的现金93,672,653.440,513,938.27213,979,553.98146,213,331.09
  经营活动现金流出小计210,556,852.34100,936,037.02459,687,238.4323,579,478.12
  经营活动产生的现金流量净额11,404,304.2410,951,710.8527,078,735.8230,441,953.96
二、投资活动产生的现金流量:
  收回投资收到的现金71,701,415.0260,627,658.1149,151,187.241,364,233.93
  取得投资收益收到的现金11,666,387.48485,589.5342,294,822.7432,728,369.47
  处置固定资产、无形资产和其他长期资产收回的现金净额--180,000180,000
  收到的其他与投资活动有关的现金670,949,000344,804,0001,048,683,582.031,879,895,582.03
  投资活动现金流入小计754,316,802.5405,917,247.641,140,309,591.971,954,168,185.43
  购建固定资产、无形资产和其他长期资产支付的现金15,917,207.173,714,866.06100,281,404.5345,066,852.55
  支付其他与投资活动有关的现金721,154,000366,184,0001,085,753,698.631,945,170,852.8
  投资活动现金流出小计737,071,207.17369,898,866.061,186,035,103.161,990,237,705.35
  投资活动产生的现金流量净额17,245,595.3336,018,381.58-45,725,511.19-36,069,519.92
三、筹资活动产生的现金流量:
  取得借款收到的现金14,475,649.32-19,987,80019,987,800
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计14,475,649.32-19,987,80019,987,800
  偿还债务支付的现金19,858,585.77---
  分配股利、利润或偿付利息支付的现金14,871,012.82245,443.17250,888.94-
  筹资活动现金流出平衡项目000-
  筹资活动现金流出小计34,729,598.59245,443.17250,888.94-
  筹资活动产生的现金流量净额-20,253,949.27-245,443.1719,736,911.0619,987,800
四、汇率变动对现金及现金等价物的影响-797,357.78-400,326.58-528,891.61-298,613.9
五、现金及现金等价物净增加额7,598,592.5246,324,322.68561,244.0814,061,620.14
  加:期初现金及现金等价物余额75,823,934.3975,823,934.3975,262,690.3175,262,690.31
  期末现金及现金等价物余额83,422,526.91122,148,257.0775,823,934.3989,324,310.45
补充资料:
  净利润-145,910,631.44-7,789,641.78-
  资产减值准备-2,137,449.51-16,823,474.14-
  固定资产和投资性房地产折旧21,477,160.38-44,541,995.11-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧21,477,160.38-44,541,995.11-
  无形资产摊销1,172,327.4-2,439,162.84-
  处置固定资产、无形资产和其他长期资产的损失---111,881.57-
  固定资产报废损失59,116.15-119,043.88-
  公允价值变动损失141,158,344.6--8,607,096.73-
  财务费用213,619.05-100,922.43-
  投资损失29,016,465.07--28,538,742.24-
  递延所得税-27,433,274.49--443,355.76-
  其中:递延所得税资产减少494,073.37--495,001.96-
    递延所得税负债增加-27,927,347.86-51,646.2-
  存货的减少-1,035,761.84-8,403,496.72-
  经营性应收项目的减少7,928,958.88--12,404,461.25-
  经营性应付项目的增加-13,279,976.05--5,488,216.07-
  其他--2,103,940.43-
  现金的期末余额83,422,526.91-50,754,290.93-
  减:现金的期初余额50,754,290.93-75,262,690.31-
  加:现金等价物的期末余额--25,069,643.46-
  减:现金等价物的期初余额25,069,643.46---
  现金及现金等价物的净增加额7,598,592.52-561,244.08-
公告日期2026-08-242026-04-292026-03-312025-10-24
审计意见(境内)标准无保留意见
TOP↑